Literature DB >> 26634239

Expanded Access to Non-VA Care Through the Veterans Choice Program. Interim final rule.

.   

Abstract

The Department of Veterans Affairs (VA) revises its medical regulations that implement section 101 of the Veterans Access, Choice, and Accountability Act of 2014 (hereafter referred to as "the Choice Act"), which requires VA to establish a program to furnish hospital care and medical services through eligible non-VA health care providers to eligible veterans who either cannot be seen within the wait-time goals of the Veterans Health Administration (VHA) or who qualify based on their place of residence (hereafter referred to as the "Veterans Choice Program" or the "Program"). These regulatory revisions are required by the most recent amendments to the Choice Act made by the Construction Authorization and Choice Improvement Act of 2014, and by the Surface Transportation and Veterans Health Care Choice Improvement Act of 2015. The Construction Authorization and Choice Improvement Act of 2014 amended the Choice Act to define additional criteria that VA may use to determine that a veteran's travel to a VA medical facility is an "unusual or excessive burden," and the Surface Transportation and Veterans Health Care Choice Improvement Act of 2015 amended the Choice Act to cover all veterans enrolled in the VA health care system, remove the 60-day limit on an episode of care, modify the wait-time and 40-mile distance eligibility criteria, and expand provider eligibility based on criteria as determined by VA. This interim final rule revises VA regulations consistent with the changes made to the Choice Act as described above.

Mesh:

Year:  2015        PMID: 26634239

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  7 in total

1.  Use of Stimulants and Performance Enhancers During and After Trauma Exposure in a Combat Veteran: A Possible Risk Factor for Posttraumatic Stress Symptoms.

Authors:  Ellen Herbst; Shannon McCaslin; Raj K Kalapatapu
Journal:  Am J Psychiatry       Date:  2017-02-01       Impact factor: 18.112

2.  Veterans' Location in Health Professional Shortage Areas: Implications for Access to Care and Workforce Supply.

Authors:  Jamie Mihoko Doyle; Robin A Streeter
Journal:  Health Serv Res       Date:  2016-12-13       Impact factor: 3.402

3.  Utilization of Care Outside the Veterans Affairs Health Care System by US Veterans With Rheumatoid Arthritis.

Authors:  Pascale Schwab; Harlan Sayles; Debra Bergman; Grant W Cannon; Kaleb Michaud; Ted R Mikuls; Jennifer Barton
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-05-09       Impact factor: 4.794

4.  Chronic disease management perspectives of colorectal cancer survivors using the Veterans Affairs healthcare system: a qualitative analysis.

Authors:  Leah L Zullig; Karen M Goldstein; Hayden B Bosworth; Sara M Andrews; Susanne Danus; George L Jackson; Dawn Provenzale; Morris Weinberger; Michael J Kelley; Corrine I Voils
Journal:  BMC Health Serv Res       Date:  2018-03-09       Impact factor: 2.655

5.  Comparison of Accessibility, Cost, and Quality of Elective Coronary Revascularization Between Veterans Affairs and Community Care Hospitals.

Authors:  Paul G Barnett; Juliette S Hong; Evan Carey; Gary K Grunwald; Karen Joynt Maddox; Thomas M Maddox
Journal:  JAMA Cardiol       Date:  2018-02-01       Impact factor: 14.676

6.  VA Telederm study: protocol for a stepped-wedge cluster randomised trial to compare access to care for a mobile app versus a workstation-based store-and-forward teledermatology process.

Authors:  Nicolae Done; Dennis H Oh; Martin A Weinstock; John D Whited; George L Jackson; Heather A King; Sara B Peracca; A Rani Elwy; Julia C Prentice
Journal:  BMJ Open       Date:  2018-12-14       Impact factor: 2.692

7.  Factors Associated With Osteoporosis Care of Men Hospitalized for Hip Fracture: A Retrospective Cohort Study.

Authors:  Samantha L Solimeo; Kimberly McCoy; Heather Schacht Reisinger; Robert A Adler; Mary Vaughan Sarrazin
Journal:  JBMR Plus       Date:  2019-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.